CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Revenue, 2025
- $4.0B
- YoY, 2025
- −0.9%
- 5-year CAGR
- +6.5%
- 10-year CAGR
- +11.4%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $4.0B | −0.9% |
| 2024 | $4.0B | −1.9% |
| 2023 | $4.1B | +3.9% |
| 2022 | $4.0B | +12.3% |
| 2021 | $3.5B | +21.1% |
| 2020 | $2.9B | +11.5% |
| 2019 | $2.6B | +15.7% |
| 2018 | $2.3B | +22.0% |
| 2017 | $1.9B | +10.5% |
| 2016 | $1.7B | +23.3% |
| 2015 | $1.4B | +5.1% |
| 2014 | $1.3B | +11.3% |
| 2013 | $1.2B | +3.2% |
| 2012 | $1.1B | −1.1% |
| 2011 | $1.1B | +0.8% |
| 2010 | $1.1B | −3.3% |
| 2009 | $1.2B | −9.5% |
| 2008 | $1.3B | — |